News

Filter

Current filters:

Licensing

101 to 110 of 96578 results

Dendreon’s Provenge too expensive to be recommended, says NICE in draft guidance

Dendreon’s Provenge too expensive to be recommended, says NICE in draft guidance

16-10-2014

In preliminary draft guidance issued this morning the UK health costs watchdog the National Institute…

BiotechnologyDendreonOncologyPricingProvengeRegulationUK

Kyorin grants R-Pharm exclusive rights to OAB drug imidafenacin in Russia

Kyorin grants R-Pharm exclusive rights to OAB drug imidafenacin in Russia

15-10-2014

Japanese drugmaker Kyorin Pharmaceutical and R-Pharm, one of Russia’s largest pharmaceutical producers,…

Genito-urinaryimidafenacinJapanKyorin PharmaceuticalsLicensingOno PharmaceuticalPharmaceuticalR-PharmRussiaStayblaUritos

Age is a factor when looking at diabetes management, Sanofi survey finds

Age is a factor when looking at diabetes management, Sanofi survey finds

15-10-2014

The US subsidiary of French pharma major Sanofi has announced the findings of a new survey that reveals…

DiabetesPharmaceuticalResearchSanofiUSA

Orexigen earns total $100 million milestone on Contrave

Orexigen earns total $100 million milestone on Contrave

15-10-2014

US biopharma company Orexigen Therapeutics says it has earned a $70 million milestone payment from partner…

ContraveFinancialMarkets & MarketingMetabolicsOrexigen TherapeuticsPharmaceuticalTakeda PharmaceuticalUSA

Japan’s Santen sets up its own subsidiary in Italy

Japan’s Santen sets up its own subsidiary in Italy

15-10-2014

Japanese mid-size ophthalmic drugmaker Santen Pharmaceutical says it has established a wholly-owned subsidiary…

CosoptItalyMarkets & MarketingOphthalmicsPharmaceuticalSaflutanSanten Pharmaceuticals

FDA grants priority reviews for Eisai's for rufinamide and lenvatinib

FDA grants priority reviews for Eisai's for rufinamide and lenvatinib

15-10-2014

There was good news for Japanese drugmaker Eisai yesterday, as the US Food and Drug Administration granted…

BanzelEisailenvatinibNeurologicalOncologyPharmaceuticalRegulationRufinamide TabletsUSA

Northwest Bio says DCVax-L hospital exemption program under way in Germany

Northwest Bio says DCVax-L hospital exemption program under way in Germany

15-10-2014

US biotech firm Northwest Biotherapeutics, which is developing DCVax personalized immune therapies for…

BiotechnologyDCVax-LGermanyNorthwest BiotherapeuticsOncologyRegulationResearch

Auspherix and Domainex collaborate for new drugs to combat antibiotic-resistance

Auspherix and Domainex collaborate for new drugs to combat antibiotic-resistance

15-10-2014

UK biotech firm Domainex and Australian drug discovery company Auspherix, a spin-out from the University…

AuspherixAuspherix PtyAustraliaBiotechnologyDomainexHealthLicensingPharmaceutical sciencesPharmacologyResearchUK

101 to 110 of 96578 results

Back to top